JP2021533128A5 - - Google Patents

Info

Publication number
JP2021533128A5
JP2021533128A5 JP2021505721A JP2021505721A JP2021533128A5 JP 2021533128 A5 JP2021533128 A5 JP 2021533128A5 JP 2021505721 A JP2021505721 A JP 2021505721A JP 2021505721 A JP2021505721 A JP 2021505721A JP 2021533128 A5 JP2021533128 A5 JP 2021533128A5
Authority
JP
Japan
Prior art keywords
subject
pharmaceutical composition
spa
composition according
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021505721A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021533128A (ja
JP7573512B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/044023 external-priority patent/WO2020028290A1/en
Publication of JP2021533128A publication Critical patent/JP2021533128A/ja
Publication of JP2021533128A5 publication Critical patent/JP2021533128A5/ja
Application granted granted Critical
Publication of JP7573512B2 publication Critical patent/JP7573512B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021505721A 2018-08-01 2019-07-30 神経変性障害を治療するための方法 Active JP7573512B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862713061P 2018-08-01 2018-08-01
US62/713,061 2018-08-01
PCT/US2019/044023 WO2020028290A1 (en) 2018-08-01 2019-07-30 Methods for treating neurodegenerative disorders

Publications (3)

Publication Number Publication Date
JP2021533128A JP2021533128A (ja) 2021-12-02
JP2021533128A5 true JP2021533128A5 (cg-RX-API-DMAC7.html) 2022-08-04
JP7573512B2 JP7573512B2 (ja) 2024-10-25

Family

ID=67614642

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021505721A Active JP7573512B2 (ja) 2018-08-01 2019-07-30 神経変性障害を治療するための方法

Country Status (27)

Country Link
US (2) US12083082B2 (cg-RX-API-DMAC7.html)
EP (1) EP3829563B1 (cg-RX-API-DMAC7.html)
JP (1) JP7573512B2 (cg-RX-API-DMAC7.html)
KR (1) KR102716959B1 (cg-RX-API-DMAC7.html)
CN (1) CN112867485A (cg-RX-API-DMAC7.html)
AU (1) AU2019315853B2 (cg-RX-API-DMAC7.html)
BR (1) BR112021001739A2 (cg-RX-API-DMAC7.html)
CL (1) CL2021000269A1 (cg-RX-API-DMAC7.html)
DK (1) DK3829563T3 (cg-RX-API-DMAC7.html)
EA (1) EA202190406A1 (cg-RX-API-DMAC7.html)
ES (1) ES3011716T3 (cg-RX-API-DMAC7.html)
FI (1) FI3829563T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20250206T1 (cg-RX-API-DMAC7.html)
HU (1) HUE070101T2 (cg-RX-API-DMAC7.html)
IL (1) IL280424B2 (cg-RX-API-DMAC7.html)
LT (1) LT3829563T (cg-RX-API-DMAC7.html)
MX (1) MX2021001287A (cg-RX-API-DMAC7.html)
MY (1) MY206530A (cg-RX-API-DMAC7.html)
PH (1) PH12021550213A1 (cg-RX-API-DMAC7.html)
PL (1) PL3829563T3 (cg-RX-API-DMAC7.html)
PT (1) PT3829563T (cg-RX-API-DMAC7.html)
RS (1) RS66516B1 (cg-RX-API-DMAC7.html)
SG (1) SG11202100767XA (cg-RX-API-DMAC7.html)
SI (1) SI3829563T1 (cg-RX-API-DMAC7.html)
SM (1) SMT202500080T1 (cg-RX-API-DMAC7.html)
UA (1) UA130011C2 (cg-RX-API-DMAC7.html)
WO (1) WO2020028290A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2021001287A (es) * 2018-08-01 2021-07-15 Alzheon Inc Métodos para tratar trastornos neurodegenerativos.
PH12021553196A1 (en) * 2019-06-17 2022-11-07 Alzheon Inc Methods for treating neurodegenerative disorders
AU2022405026A1 (en) * 2021-12-09 2024-06-20 Alzheon, Inc. Alz-801 for use in treating alzheimer's disease

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840294A (en) * 1993-03-29 1998-11-24 Queen's University At Kingston Method for treating amyloidosis
SI2089417T1 (sl) * 2006-10-12 2015-04-30 Bhi Limited Partnership Metode, spojine, sestavki in vektorji za dostavo 3-amino-1-propansulfonske kisline
EP2852388A4 (en) 2012-05-23 2016-01-13 Univ Johns Hopkins COMPOUNDS AND METHOD FOR USE THEREOF FOR THE TREATMENT OF NEURODEEGENERATIVE DISEASES
WO2014121083A1 (en) * 2013-01-31 2014-08-07 President And Fellows Of Harvard College Methods of increasing neuronal connectivity and/or treating a neurodegenerative condition
ES2960625T3 (es) * 2014-03-21 2024-03-05 Alzheon Inc Compuestos para uso en el tratamiento de la enfermedad de Alzheimer en pacientes de ApoE4+/+
EP3347002B1 (en) * 2015-09-10 2023-06-07 Alzheon, Inc. Treatment of alzheimer's disease in a particular patient population
MX2021001287A (es) * 2018-08-01 2021-07-15 Alzheon Inc Métodos para tratar trastornos neurodegenerativos.

Similar Documents

Publication Publication Date Title
JP7862354B2 (ja) 補体活性のモジュレーター
Cascino et al. Plasma and cerebrospinal fluid amino acid patterns in hepatic encephalopathy
JP2009542611A (ja) アルファ−シヌクレイン凝集の阻害
US20200392181A1 (en) Peptide compositions and related methods
FI3746467T3 (fi) Muutetut lipidoidut relaksiinin b-ketjun peptidit ja niiden terapeuttinen käyttö
JP2004521123A5 (cg-RX-API-DMAC7.html)
JP2021527670A5 (cg-RX-API-DMAC7.html)
WO2018048944A1 (en) Methods of treating iron overload
TWI866551B (zh) 穩定抗體組合物
TW200410681A (en) Amino acid compound for improving central function
JP7573512B2 (ja) 神経変性障害を治療するための方法
AU2017319512A2 (en) Use of CGRP receptor antagonists in neuroprotection and neurological disorders
JP7784378B2 (ja) タウオパチーを処置するためのペプチド組成物及び方法
CN115279341A (zh) 胰高血糖素类似物的液体制剂
TH2101000540A (th) องค์ประกอบทางเภสัชกรรมที่ประกอบรวมด้วยกรดซัลโฟโพรพาโนอิกสำหรับการผลิตยาสำหรับการรักษาความผิดปกติที่เกิดจากความเสื่อมของระบบประสาท
JP7464310B2 (ja) Wntシグナル伝達経路の抑制剤
WO2013137606A1 (ko) 동맥경화 예방 또는 치료용 약제학적 조성물
JP2001172190A (ja) 乳酸蓄積抑制剤
HK40119431A (en) Stable antibody composition
CN118984715A (zh) 包含新型肽的用于治疗黄斑变性的组合物
CN115974973A (zh) 一种抑制trpm8的多肽及其用途
CN116802208A (zh) 帕金森氏病的治疗
US20210171604A1 (en) Peptides for the treatment of type 2 diabetes
HK40031446B (en) Modulators of complement activity
BR112018012174B1 (pt) Composição farmacêutica que compreende um polipeptídeo inibidor de c5, kit, dispositivo de auto injetor e uso